Braintree Laboratories Incorporated

Braintree Laboratories, Inc. is a fully integrated, privately held US-based multinational pharmaceutical company. From the start, the company has steadily established itself as a leader in specific niches of the pharmaceutical market. The company's prescription drugs are concentrated in the areas of Gastroenterology and Nephrology. Based on audited data, Braintree Laboratories leads the market in its products' classes.

Braintree Laboratories pioneered the first gastrointestinal lavage, GoLYTELY®, introducing it in 1984. In the 1990's, Braintree has introduced a new generation of gastrointestinal lavages, NuLYTELY® and Cherry Flavored NuLYTELY®. NuLYTELY is the fastest growing flavored GI lavage bowel prep and the #1 prescribed flavored bowel cleansing preparation in the U.S.A.



In February 1999, Braintree Laboratories received approval for MiraLax™, the first prescription laxative to clear the FDA in 23 years. U.S. marketing and sales have begun and are proceeding well.



In Nephrology, Braintree Laboratories markets the leader in phosphate binders, PhosLo®. This product assists patients with the kidney condition known as End Stage Renal Disease or ESRD.



In addition to its fully staffed R&D and manufacturing divisions, Braintree Laboratories maintains a national sales force.



Due to its success in these markets, Braintree seeks new business opportunities, both for licensing in and licensing out.



In the US, Braintree seeks licenses for products in gastroenterology, nephrology and other specialty area. Overseas, Braintree seeks partners for its products MiraLax™, NuLYTELY®, GoLYTELY®, and PhosLo®, which are described in greater detail in our web site www.braintreelabs.com.





For further information, please contact:



Russell W. Pelham, Ph.D.,

Director of Business Development

Contact Details: 60 Columbian St West Braintree MA 02185 United States of America Tel: 781 843 2202 Fax: 781-843-7932 Email: WWW: www.graylab.ac.uk/cancerweb/

Loading...

Recent Publications by Braintree Laboratories Incorporated:
Clinical trial: single- and multiple-dose pharmacokinetics of polyethylene glycol (PEG-3350) in healthy young and elderly subjects. BACKGROUND: The pharmacokinetics of polyethylene glycol 3350 (PEG-3350)...	9th May, 2008	Braintree Laboratories Inc., Braintree, MA 02185, USA.	Aliment Pharmacol Ther. 2008 Jul;28(2):256-65. Epub 2008 Apr 30. DOI Direct Link

Braintree Laboratories Incorporated Patents:
US Patent No.	Title
7291324	Method of bowel cleansing
6946149	Salt solution for colon cleansing
6645481	Method of achieving overnight laxation and control of bowel function
6576665	Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
6048901	Method of reducing intestinal gas, cramping and anorectal irritation
→View more Braintree Laboratories Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 373 times since April 2007, the link to the organisation's website has been followed 36 times

Recent Search Terms used to find this page: braintree labs russ pelham | Russell Pelham Braintree Laboratories | braintree | miralax AND Pelham | bRAINTREE LABS CLINICAL STUDIES | braintree laboratories incorporated | Braintree Laboratories | Braintree Laboratories | Braintree Laboratories | Russell W Pelham | .

Search for more companies in Braintree

Search for more companies in MA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Braintree Laboratories Incorporated